Article Details
Retrieved on: 2022-02-20 09:49:39
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The fund acquired 1,500,577 shares of the company's stock, valued at approximately $12,515,000. BlackRock Inc. owned about 0.06% of Tscan Therapeutics ...
Article found on: etfdailynews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here